ePRO/eCOA White Papers & Case Studies

  1. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

    This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

  2. Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions 8/29/2026

    Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.

  3. UK Clinical Trial Regulations Reform 7/24/2026

    UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.

  4. Navigating Choppy Waters: Rapid Study Completion For An Anti-Nausea Compound 7/17/2026

    See how strategic technology reuse and real-time query resolution allow study teams to successfully manage high-volume, rapid participant enrollment without compromising data quality.

  5. Sensors And On-Demand eCOA 7/13/2026

    See how one rare disease trial eased caregiver burden by unifying glucose monitoring and patient diaries into a single app with real-time safety alerts.

  6. Visit Management Solution Built For Global Trials 7/5/2026

    From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.

  7. An eConsent Platform For Modern Clinical Trials 7/5/2026

    From signature to re-consent, manual processes add delay and risk. Discover how a digital approach to informed consent keeps studies compliant, on track, and participant-focused.

  8. Modern eConsent Built For Clinical Research Sites 6/24/2026

    We partnered with leading academic medical centers, sponsors, hospital systems, and site networks to create an eConsent platform that is easy-to-use and minimizes risk.

  9. Meeting The FDA's New Real-World Evidence Standards 5/27/2026

    FDA guidance is reshaping RWE strategy. Sponsors that build interoperable, audit-ready RWD infrastructure now will be best positioned for faster, defensible submissions.

  10. The eCOA Iceberg 5/27/2026

    Understand the true cost of eCOA deployment, beyond software licenses, to reduce protocol risk, avoid operational bottlenecks, and protect study timelines and data quality.